A few African countries are using Pfizer/BioNTech's mRNA vaccine as part of their COVID-19 vaccination programmes. By that measure, they're 'available'. Pfizer

A few African countries are using Pfizer/BioNTech's mRNA vaccine as part of their COVID-19 vaccination programmes. By that measure, they're 'available'. Pfizer/BioNTech have also signed an agreement with South Africa's Biovac Institute for the 'fill and finish' manufacturing of their COVID-19 mRNA vaccine. It's not nearly enough of course, and no substitute for full-blown IP waivers and technology transfer. In fact you could argue they've been forced into this by the threat of those waivers. But it's not nothing.